Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Strassl

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 18, 2011
Rapid identification of neuraminidase inhibitor resistance mutations in seasonal influenza virus A(H1N1), A(H1N1)2009, and A(H3N2) subtypes by melting point analysisM Redlberger-Fritz, S W Aberle, R Strassl, et al.
Public Health|January 20, 2024
On the impact of surveillance test strategies: a cost-benefit modelling analysis based upon real-world data from SARS-CoV-2T Spath, M Kundi, R Strassl, et al.
Zeitschrift Fur Orthopadie Und Unfallchirurgie|April 10, 2009
[Long-term results of the cementless Hofer-Imhof threaded titanium cup]G Metzner, R Strassl, D R P Neumann, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|September 14, 2013
Analysis of plasma surfactant protein D levels in lung transplant recipientsI Bejvl, L Weseslindtner, R Strassl, et al.
Journal of Viral Hepatitis|October 10, 2012
Five-year on-treatment efficacy of lamivudine-, tenofovir- and tenofovir + emtricitabine-based HAART in HBV-HIV-coinfected patientsL Kosi, T Reiberger, B A Payer, et al.
Journal of Viral Hepatitis|October 12, 2013
Viral determinants predicting hepatitis B surface antigen (HBsAg) seroclearance in HIV-/HBV-coinfected patientsR Strassl, T Reiberger, C Honsig, et al.
Alimentary Pharmacology & Therapeutics|May 29, 2013
Durability of SVR in chronic hepatitis C patients treated with peginterferon-α2a/ribavirin in combination with a direct-acting anti-viralK Rutter, H Hofer, S Beinhardt, et al.
Journal of Internal Medicine|March 2, 2021
Arterial stiffness in acute COVID-19 and potential associations with clinical outcomeS Schnaubelt, J Oppenauer, D Tihanyi, et al.
Alimentary Pharmacology & Therapeutics|November 12, 2013
Polymorphisms of interferon-λ4 and IL28B - effects on treatment response to interferon/ribavirin in patients with chronic hepatitis CA F Stättermayer, R Strassl, A Maieron, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 18, 2011
Rapid identification of neuraminidase inhibitor resistance mutations in seasonal influenza virus A(H1N1), A(H1N1)2009, and A(H3N2) subtypes by melting point analysisM Redlberger-Fritz, S W Aberle, R Strassl, et al.
Public Health|January 20, 2024
On the impact of surveillance test strategies: a cost-benefit modelling analysis based upon real-world data from SARS-CoV-2T Spath, M Kundi, R Strassl, et al.
Zeitschrift Fur Orthopadie Und Unfallchirurgie|April 10, 2009
[Long-term results of the cementless Hofer-Imhof threaded titanium cup]G Metzner, R Strassl, D R P Neumann, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|September 14, 2013
Analysis of plasma surfactant protein D levels in lung transplant recipientsI Bejvl, L Weseslindtner, R Strassl, et al.
Journal of Viral Hepatitis|October 10, 2012
Five-year on-treatment efficacy of lamivudine-, tenofovir- and tenofovir + emtricitabine-based HAART in HBV-HIV-coinfected patientsL Kosi, T Reiberger, B A Payer, et al.
Journal of Viral Hepatitis|October 12, 2013
Viral determinants predicting hepatitis B surface antigen (HBsAg) seroclearance in HIV-/HBV-coinfected patientsR Strassl, T Reiberger, C Honsig, et al.
Alimentary Pharmacology & Therapeutics|May 29, 2013
Durability of SVR in chronic hepatitis C patients treated with peginterferon-α2a/ribavirin in combination with a direct-acting anti-viralK Rutter, H Hofer, S Beinhardt, et al.
Journal of Internal Medicine|March 2, 2021
Arterial stiffness in acute COVID-19 and potential associations with clinical outcomeS Schnaubelt, J Oppenauer, D Tihanyi, et al.
Alimentary Pharmacology & Therapeutics|November 12, 2013
Polymorphisms of interferon-λ4 and IL28B - effects on treatment response to interferon/ribavirin in patients with chronic hepatitis CA F Stättermayer, R Strassl, A Maieron, et al.
Pageof 1